WAVE Life Sciences (WVE) Misses Q4 EPS by 3c

WAVE Life Sciences (NASDAQ: WVE) reported Q4 EPS of ($0.30), $0.03 worse than the analyst estimate of ($0.27). Revenue for the quarter came in at $17.24 million versus the consensus estimate of $17.16 million.

For earnings history and earnings-related data on WAVE Life Sciences (WVE) click here.

You May Also Be Interested In

• Corning (GLW) files for up to $2B offering of common shares
• BetterLife Pharma files final prospectus for $100M public offering
• Rent the Runway (RENT) Reports Q2 Loss of $0.38/sh